Hormone therapy use and outcomes in the Women's Health Initiative trials--reply.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Joann E
JE
Manson
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California.
Rowan T
RT
Chlebowski
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Aaron K
AK
Aragaki
D001943:Breast Neoplasms / Q000517:prevention & control*; D003327:Coronary Disease / Q000517:prevention & control*; D004967:Estrogens / Q000008:administration & dosage*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate